Skip to main content
PLOS One logoLink to PLOS One
. 2020 Jun 24;15(6):e0235127. doi: 10.1371/journal.pone.0235127

Repeat induces not only gene silencing, but also gene activation in mammalian cells

Yusuke Ogaki 1, Miki Fukuma 1, Noriaki Shimizu 1,*
Editor: Arthur J Lustig2
PMCID: PMC7313748  PMID: 32579599

Abstract

Repeat-induced gene silencing (RIGS) establishes the centromere structure, prevents the spread of transposons and silences transgenes, thereby limiting recombinant protein production. We previously isolated a sequence (B-3-31) that alleviates RIGS from the human genome. Here, we developed an assay system for evaluating the influence of repeat sequences on gene expression, based on in vitro ligation followed by our original gene amplification technology in animal cells. Using this assay, we found that the repeat of B-3-31, three core sequences of replication initiation regions (G5, C12, and D8) and two matrix attachment regions (AR1 and 32–3), activated the co-amplified plasmid-encoded d2EGFP gene in both human and hamster cell lines. This upregulation effect persisted for up to 82 days, which was confirmed to be repeat-induced, and was thus designated as a repeat-induced gene activation (RIGA). In clear contrast, the repeat of three bacterial sequences (lambda-phage, Amp, and ColE1) and three human retroposon sequences (Alu, 5’-untranslated region, and ORF1 of a long interspersed nuclear element) suppressed gene expression, thus reflecting RIGS. RIGS was CpG-independent. We suggest that RIGA might be associated with replication initiation. The discovery of RIGS and RIGA has implications for the repeat in mammalian genome, as well as practical value in recombinant production.

Introduction

Amplification of oncogenes or drug-resistant genes plays a pivotal role in malignant transformation of human cells. Amplified genes frequently localize at the extrachromosomal double minutes (DMs) or the chromosomal homogeneously staining region (HSR). We have previously reported that a plasmid bearing both a replication initiation region (IR) and a nuclear matrix attachment region (MAR) efficiently mimics gene amplification, and spontaneously generates DMs and HSR in transfected cells [1, 2]. Since this discovery, we have been using this IR/MAR gene amplification technology to uncover the underlying mechanism of gene amplification [35], investigate basic cell biology (see [6] for an early review), and efficiently produce recombinant proteins [79]. However, for recombinant proteins production, a major drawback was that protein production did not necessarily increase in proportion to the increase in gene copy number [10], since the amplified genes frequently formed a silent chromatin [11, 12]. This was caused by IR/MAR plasmid amplification into the tandem repeat structure [2], which was easily silenced by a mechanism known as repeat-induced gene silencing (RIGS) (for reviews see [13, 14]).

RIGS has an important cellular function by heterochromatinizing repeated sequences, such as those in the pericentric region to increase mechanical strength [15], ultimately silencing the repeated transposon sequence to prevent its spread [16] with a similar effect to transfected genes [17, 18]. Furthermore, 250 to 670 copies of ribosomal DNA were tandemly repeated in diploid human genome, however only a fraction of them is transcriptionally active [19]. The involvement of an RNA interference mechanism was proposed to silence the tandem repeat [2022]. RNA interference was also suggested for nucleolar organization and repeated DNA stability [23] or pericentric heterochromatin formation [24]. Involvement of RNA interference in the latter case was bypassed by the elimination of histone H3K14 acetyl transferase [15]. Heterochromatin assembly in transgene repeats is independent of RNA interference [25]}. It has recently been reported that a complex bearing retinoblastoma protein extensively occupies and represses expression of genomic tandem repeat [26].

Our previous investigation of the epigenetic chromatin status of amplified sequences at the DMs or HSRs, generated using our IR/MAR technology, led us to propose the “DNA methylation-core and heterochromatin-spread” model for RIGS [12]. To alleviate RIGS, we screened the human genomic library and obtained a 3,271-bp sequence, named “B-3-31”, that enhanced gene expression from tandemly amplified repeats [27]. Further, we determined the core (minimum) sequences that supported gene amplification inside the c-myc IR (2349 bp), DHFR IR (Oriβ; 4634 bp), and β-globin Rep-P IR (2771 bp), and obtained the sequences “C12” (798 bp) [28], “D8” (2347 bp) [28], and “G5” (972 bp) [29], respectively. Importantly, when we ligated G5 DNA to the direct or inverted repeat in vitro, the G5 repeat DNA was efficiently amplified in the transfected cells, similar to the IR/MAR plasmid amplification [30]. Furthermore, the co-transfected plasmid was co-amplified in the long stretch of amplified G5, and expression from the plasmid-encoded genes was significantly upregulated [30]. Although this increase in gene expression might be expected since G5 is a core IR, and IRs were reported to upregulate neighboring genes [31], the fact that repeated G5 was transfected and then further amplified in cells suggested that the repeat per se does not necessarily result in RIGS, and that another type of repeat might instead efficiently upregulate the neighboring gene. We named this hypothetical phenomenon as “repeat-induced gene activation (RIGA)” as a contrast to the RIGS phenomenon. Thus, the aim of the present study was to verify the existence of sequence-dependent RIGA.

Materials and methods

Experimental design to evaluate RIGS or RIGA

The overall strategy is outlined in Fig 1A. We have previously found that any DNA, including lambda-phage DNA, might be co-amplified in the cells when co-transfected with an IR/MAR plasmid [2]. Subsequently, we conducted a series of experiments to exploit this phenomenon for amplifying various sequences in cells (e.g., [3, 9, 32, 33]. The co-transfected DNA was recombined in the cells, and was further multimerized to a large circular molecule, in which the transfected sequences were arranged as direct repeats [2]. This DNA could frequently recombine with extrachromosomal DMs if present in the same cells [3]. Such extrachromosomal DNA of tandem repeats might then be integrated to the chromosome arm and further amplified by inducing the breakage-fusion-bridge cycle to generate HSR [3]. Based on these previous findings, we used this system to evaluate whether the repeat of a test sequence may downregulate or upregulate the expression of the gene of interest, destabilized enhanced green fluorescent protein (d2EGFP) in this case, among the amplified tandem array of transfected sequences generated in cells. briefly, the test sequence was amplified using polymerase chain reaction (PCR), digested by RsrII at the PCR primer, and ligated in vitro. Since RsrII recognizes a non-palindromic sequence, the ligation produces only the direct repeat of the test sequence. The repeat DNA was then mixed with the DNA of an IR/MAR-bearing plasmid (pΔBM d2EGFP) in most experiments, and co-transfected in human and hamster cells, respectively, as detailed below.

Fig 1. Overview of the experimental set-up to evaluate RIGS ad RIGA.

Fig 1

(A) Schematic of the experimental strategy. (B) Preparation of a direct-repeat DNA sequence using PCR amplification, RsrII digestion, and ligation. (C) Structure of the plasmids used in this study. (D) Electrophoretic analyses of the ligation products introduced to the cells. M; molecular weight marker, -; unligated DNA, L; ligated DNA.

Preparation of repeat DNA

The following sequences were PCR-amplified using the primers listed in S1 Fig. Human genomic B-3-31 (3271 bp) [27] was cloned from a human genomic library, which was previously shown to alleviate RIGS as demonstrated by the amplified IR/MAR plasmid. B-3-31 was originally cloned at the AscI site of the IR/MAR-bearing plasmid pΔBM d2EGFP. AR1 (377 bp) is an intronic MAR from the mouse Igκ gene [34], which we have frequently used for IR/MAR amplification in previous studies. Sequence 32–3 (773 bp) is an unpublished sequence, which was a kindly gifted by Dr. Ken Tsutsui (Okayama University). This sequence was originally cloned from rat genomic library and showed strong in vitro MAR activity (Ken Tsutsui, personal communication). The sequences G5 (971 bp [29]), C12 (798 bp [28]), and D8 (2347 bp [28]) are core IRs from the β-globin, c-myc, and DHFR genes, respectively, and were isolated as the shortest sequences capable of supporting gene amplification. The lambda-phage sequence used in this study was derived from position 1891–2966 (1076 bp) of lambda-phage (NCBI NC_001416.1). The ampicillin-resistance gene sequence was derived from position 6171–7031 (861 bp) of pCEP4 (10,186 bp; https://www.snapgene.com/resources/plasmid-files/?set=mammalian_expression_vectors&plasmid=pCEP4), and the Colicin E1 (ColE1) sequence was derived from position 2594–3136 (543 bp; ORF frame 1 in https://www.addgene.org/browse/sequence_vdb/1433/). The Alu sequence was derived from position 52–129 (78 bp) of the consensus sequence appearing in Weisenberger et al. [35]. The long interspersed nuclear element (LINE) sequence was obtained from https://www.ebi.ac.uk/ena/data/view/AH005269, and the 5′ untranslated region (UTR; position 306–1214, 909 bp) and ORF1 (position 1216–2232; 1017 bp) were amplified using human genomic DNA as a template.

Each PCR primer had a 20-nt sequence specific to the target, which was followed by an 11–14-nt sequence with a RsrII recognition site at the 5′ end. Rsr II cuts non-palindromic sequences, which can only be ligated as a direct repeat (Fig 1B). Following PCR amplification using these primer sets, KOD-Plus Neo DNA polymerase (Toyobo Co.), and template DNA, the products were digested by RsrII (New England Biolabs Inc.). The DNA was purified using NucleoSpin1 Gel and PCR Clean-up kits, according to the manufacturer instructions, (MACHEREY-NAGEL Co.) and was ligated using Ligation high Ver.2 (TOYOBO Co.). The ligated DNA was purified by phenol/chloroform extraction and ethanol precipitation, and finally used for cell transfection. The electrophoretic analysis of the preparation is shown in Fig 1D.

Plasmids

The repeat DNA was mixed with the plasmids pKV, pKV-AR1, and pΔBM.d2EGFP (Fig 1C) for transfection. Construction of pKV and pKV-AR1 has been described elsewhere [30]. pKV contained a blasticidin resistance gene (BSR) and d2EGFP expression cassette. pKV-AR1 (Fig 1C) had a similar structure, but further contained the AR1 sequence from a mouse Igk intron that showed strong in vitro MAR activity as described above [34]. Construction of pΔBM d2EGFP was conducted as described previously [36], with a nearly identical sequence to that of pKV in addition to the DHFR IR (Oriβ; 4,634 bp) harboring a sequence with in vitro MAR activity [1].

Cells, culture, and transfection

The human colorectal carcinoma COLO 320DM cell line was used as for transfection since it can efficiently amplify the IR/MAR plasmid [1]}. COLO 320DM (CCL-220) cells were originally obtained from the American Type Culture Collection (Manassas, VA, USA), and clone “COLO 320DM #3” bearing multiple DMs with an amplified c-myc oncogene was obtained by limiting dilution [37]. COLO 320DM cells were cultured in RPMI 1640 medium (Nissui Pharmaceutical Co. Ltd.) supplemented with 10% fetal calf serum (FCS). In addition, the Chinese hamster CHO DG44 cell line (commonly used in industrial recombinant production) was used for evaluation of the practical feasibility of our strategy. CHO DG44 cells were obtained as previously described [8], and cultured in Ham’s F-12 medium (Nacalai Tesque Inc.) supplemented with 10% FCS. COLO 320DM cells were transfected using GenePORTER2 Transfection Reagent (Genlantis Co.), whereas CHO DG44 cells were transfected using Lipofectamine 2000 Reagent (ThermoFisher Scientific Co.) according to the manufacturers’ recommended protocols. Stable transformants were selected by blasticidin.

FISH, flow cytometric analysis and other methods

Metaphase chromosome spreads were prepared according to a standard protocol. A DIG- or biotin-labeled probe was prepared from template DNA using BioPrime DNA Labeling Kit (Invitrogen) with or without 10× DIG DNA Labeling Mixture (Roche), respectively. For flow cytometric analysis to evaluate d2EGFP expression, cells were resuspended in phosphate-buffered saline and analyzed using the FACS Calibur system (Becton Dickinson Co.) in the absence or the presence of sodium butyrate for the final 3 days of culturing. The bisulfite treatment followed by the nucleotide sequencing was conducted as previously described [12].

Results

The B-3-31 or G5 repeat exhibited long-lasting RIGA

Addition of the B-3-31 or G5 repeat sequence consistently increased the expression of d2EGFP from all three vector constructs (pKV, pKV-AR1, and pΔBM.d2EGFP) with or without IR and/or MAR in both the hamster CHO DG44 and human COLO 320DM cells with or without butyrate addition (Fig 2A and 2B). Sodium butyrate, an inhibitor of histone deacetylase complex [38], augmented the expression from the epigenetically silenced repeated sequence [8, 10, 27]. Expression enhancement by B-3-31 or G5 repeat was reproducible among different transfections (see below and S2 Fig) and was statistically significant. Despite only pΔBM.d2EGFP contained the IR/MAR, the repeat of G5, as a core IR, was spontaneously amplified in cells as in the case of the IR/MAR plasmid [30], and the same effect was found for the B-3-31 repeat. Therefore, the expression from all three plasmids was elevated by co-amplification with the B-3-31 or G5 repeat, regardless of the presence of IR/MAR in the plasmid.

Fig 2. The B-3-31 repeat or G5 repeat exhibited RIGA.

Fig 2

B-3-31 repeat or G5 repeat DNA was co-transfected with pKV, pKV-AR1 (with a MAR), or pΔBM.d2EGFP (with an IR/MAR) to CHO DG44 cells (A) or COLO 320DM cells (B). The transfected cells were cultured in the presence of 5 μg/ml blasticidin for 39 days (A) or 54 days (B), and analyzed using flow cytometry in the absence (blue-filled lines) or presence (unfilled lines) of 2 mM sodium butyrate during the final 3 days of culturing. The mean fluorescence intensity for the butyrate-absent and butyrate-present (in parentheses) condition is indicated in each graph. (C) The COLO 320DM cells transfected with pΔBM.d2EGFP or pKV-AR1 with or without the G5 repeat were cultured in the presence of blasticidin for 34, 62, and 82 days, and analyzed as described above. (D) pΔBM.d2EGFP, pΔBM.d2EGFP bearing B-3-31 at the AscI site (see Fig 1B), or pΔBM.d2EGFP mixed with B-3-31 repeat DNA was transfected to CHO DG44 cells or COLO 320DM cells, and cultured for 19 days or 36 days, respectively, in the presence of blasticidin. The cells were analyzed using flow cytometry in the absence of butyrate. Unfilled lines show the results for pΔBM.d2EGFP alone and the gray-filled lines show the results for the other two transformants.

This elevated expression persisted for up to 82 days following transfection (Fig 2C), thus indicating the stability of expression enhancement. By contrast, the expression level from the single transfection of pΔBM.d2EGFP or pKV AR1 gradually decreased during this same period (Fig 2C), likely reflecting RIGS of the amplified sequences. Furthermore, co-transfection of pΔBM.d2EGFP and B-3-31 repeat DNA was more effective in elevating gene expression compared to transfection of the pΔBM.d2EGFP vector harboring a cloned B-3-31 sequence (Fig 2D). A similar result was obtained for the G5 repeat in our previous study [30], indicating that enhancement of gene expression by the B-3-31 or G5 repeat was repeat-dependent.

The core IR or MAR repeats exhibited RIGA

Expression of d2EGFP was consistently higher in the culture co-transfected with the core IR from the c-myc locus (C12) or DHFR locus (D8) or MAR repeat DNA (AR-1 and 32–3), compared with that in the culture transfected with pΔBM.d2EGFP alone (Fig 3A and 3B). This effect was observed in both cell lines with and without butyrate addition. Only the C-12 repeat had no significant effect in CHO DG44 cells, whereas it enhanced target gene expression in COLO 320DM cells. Such observation was reproducible among different transfection (S3 Fig). This likely reflects the less efficient amplification of the IR/MAR-containing plasmid in CHO DG44 cells compared to COLO 320DM cells [29].

Fig 3. The core-IR repeat, or MAR repeat exhibited RIGA, whereas the lambda-phage repeat had the opposite effect on gene expression.

Fig 3

CHO DG44 cells or COLO 320DM cells were transfected with pKV, pΔBM.d2EGFP mixed without or with the repeat DNA from B-3-31 as well as C12 or D8 (A), or AR-1, 32–3, or lambda-phage (B). The data shown represent independent transfections. Transfected CHO DG44 cells were cultured in the presence of blasticidin for 31 (A) or 30 (B) days, and COLO 320DM cells were cultured for 56 (A) and 59 (B) days. Flow cytometry results were obtained in the absence (blue-filled lines) or presence (unfilled lines) of 2 mM sodium butyrate during the final 3 days of culturing. The mean fluorescence intensity for the butyrate-absent and butyrate-present (in parentheses) condition is indicated noted in each graph.

Therefore, B-3-31, the three core IRs (G5, C12, and D8), and two MARs (AR1 and 32–3) exhibited RIGA. By contrast, under the same experimental conditions (Fig 3B), the repeat of the lambda phage-derived sequence resulted in no apparent change in the expression from amplified pΔBM.d2EGFP in CHO DG44 cells, but rather suppressed the expression to a level lower than that induced by pΔBM.d2EGFP alone in COLO 320DM cells, especially in the butyrate-containing culture. It was considered to reflect RIGS.

The bacterial sequence and human transposon exhibited RIGS

We next examined the influence of plasmid-derived ColE1, an ampicillin-resistant gene, and three different transposon sequences that are most abundant in the human genome (5′ UTR of LINE, ORF1 of LINE, and Alu). The repeat of all these sequences suppressed gene expression to a level lower than that observed with transfection of pΔBM.d2EGFP alone in both cell lines (Fig 4). This suppressive effect was the most prominent with transfection to COLO 320DM cells and in the presence of butyrate, which was similar to the results obtained for the lambda-phage repeat described above. IR/MAR gene amplification usually proceeds far more efficiently in COLO 320DM cells than in CHO DG44 cells [8, 29], which explains the stronger effect in COLO 320DM cells. The amplified sequences generated from RIGS-inducing sequences in COLO 320DM cells should form tightly compacted chromatin that might not be relaxed by butyrate treatment as a histone deacetylase complex inhibitor. By contrast, the B-3-31 repeat still efficiently enhanced expression of the target gene in the same experiment (Fig 4).

Fig 4. The plasmid or transposon repeat exhibited RIGS.

Fig 4

(A) CHO DG44 cells or COLO 320DM cells were transfected with pKV, pΔBM.d2EGFP mixed with or without the repeat of B-3-31, plasmid-derived ampicillin resistance gene, Colicin E1, 5′ UTR or ORF1 of human LINE, and human Alu. The stable transformants were selected by blasticidin for 23 days for CHO DG44 cells or for 37 days for COLO 320DM cells. Flow cytometry results were obtained in the absence (blue-filled lines) or presence (unfilled lines) of 2 mM sodium butyrate during the last 3 days. The mean fluorescence intensity for the butyrate-absent and butyrate-present (in parentheses) condition is noted in each graph.

Statistical significance of RIGS and RIGA

We conducted multiple independent co-transfections of various kinds of plasmids combined with/without B-3-31 or G5 repeats. We then plotted all mean fluorescence intensities values from the flow cytometric analyses as shown in Fig 5. We applied student’s t-test to these values and obtained p-values for the expression enhancement by the addition of repeat compared to the plasmid alone (Fig 5A for CHO DG44 and B for COLO 320DM). Results showed that the addition of B-3-31 repeat significantly (p < 0.05) elevated the expression from the plasmid in both CHO DG44 and COLO 320DM cell lines. The statistical significance of the addition of G5 repeat was slightly insufficient in CHO DG44 cells, since the number of samples (n) was only 3; however, it was significance in the COLO 320DM cells.

Fig 5. Statistical significance of RIGS and RIGA.

Fig 5

The mean fluorescence intensities of flow cytometric analyses, shown in Figs 24, were plotted in graphs. The p-values for the expression enhancement by the addition of B-3-31 or G5 repeat compared to the plasmid alone were calculated and shown in the tables, for CHO DG44 cells (A) and for COLO 320DM cells (B). The p-values for the difference between the effects of 6 different RIGA and 6 different RIGS sequences were calculated and shown in the tables, for CHO DG44 cells (C) and for COLO 320DM cells (D).

In the above experiments, we have analyzed 6 kinds of sequences that showed RIGA and 6 kinds that showed RIGS. We plotted all mean fluorescence intensities values obtained from the flow cytometric analyses as shown in Fig 5C (CHO DG44) and 5D (COLO 320DM). We then applied student’s t-test and obtained p-values for the significant differences between RIGA and RIGS sequences (Fig 5C and 5D). The results showed that, although p-value for butyrate-treated CHO cells was 0.058, the difference was statistically significant (p < 0.05) in all other cases.

CpG content had no effect on gene expression

We previously proposed the “DNA methylation-core and chromatin-spread model” to explain heterochromatin formation by RIGS [12]. Because CpG is methylated in mammalian cells, we determined the CpG content among the sequences examined in this study. Almost all sequences exhibiting RIGA had a low CpG content, whereas most sequences exhibiting RIGS had a high CpG content, except for C12 and ORF1 of LINE (Fig 6A). C12 is located at the c-myc promoter region, and thus might represent a CpG island. ORF1 of LINE had a lower CpG content among the RIGS sequences, but it remained much higher than that of the RIGA sequence. This clear difference of CpG content between RIGS and RIGA sequences suggested that the high CpG content in RIGS sequences might initiate repeat heterochromatinization. To validate this, we treated the lambda-phage DNA with bisulfite to convert unmethylated cytosine to uracil, which was then cloned in Escherichia coli cells. The sequenced result (Fig 6B) revealed the successful conversion from C to T, which diminished the CpG content and consequently increased the AT content. Compared with the untreated sequence, bisulfite treatment of the lambda-phage sequence had no effect on the gene expression from pΔBM.d2EGFP, both when the repeat DNA was co-transfected with pΔBM.d2EGFP (Fig 6C) and when the sequence was cloned in pΔBM.d2EGFP (Fig 6D). However, in the same experiment, the B-3-31 repeat significantly enhanced gene expression.

Fig 6. Influence of CpG content on gene expression.

Fig 6

(A) CpG content of the sequences examined in this study. (B) Lambda-phage DNA was treated with bisulfite to convert unmethylated cytosine to uracil, followed by PCR amplification and cloning in E. coli host cells. The extent of conversion was determined by sequencing. (C) The repeat DNA of untreated or bisulfite-treated sequences was mixed with pΔBM.d2EGFP and co-transfected to CHO DG44 cells. (D) The B-3-31, untreated or bisulfite-treated lambda-phage sequence was cloned in pΔBM.d2EGFP and transfected to CHO DG44 cells. Cells were cultured in medium containing blasticidin for 24 (C) or 52 (D) days, and d2EGFP expression was analyzed using flow cytometry in the absence of butyrate. Unfilled lines indicate pΔBM.d2EGFP single transformants and gray-filled lines indicate the test transformants.

Autonomous replication initiation might be related to RIGA

During this study, we found that the transformation efficiency, as judged by the primary colony number, was significantly higher with transfection of the RIGA repeats (Fig 7A). A high transformation efficiency is usually considered to reflect episomal replication of the transfected DNA, and the autonomous replication sequence was cloned in yeast cells based on the increase in the transformation efficiency [39]. Furthermore, we routinely observed a higher transformation efficiency from the IR/MAR plasmid compared to the normal plasmid [30], which explains the higher colony number of pΔBM.d2EGFP than pKV (Fig 7A). Such enhancement by IR/MAR was more evident in the number of small colonies comprising less than 100 cells. Such small colony is thought to reflect the transient episomal maintenance during the initial few days following the transfection. We found that the transfection of the RIGA repeat produced higher colony number, especially for the small colony, while RIGS repeat did not (Fig 7A).

Fig 7. RIGA repeats might support extrachromosomal replication initiation.

Fig 7

(A) Thirteen (Exp. 1, 3) or 22 (Exp. 2) days following transfection of the indicated DNA to CHO DG44 cells, the colony number per dish was counted and plotted; a small and large colony was defined as a colony comprising less than or more than 100 cells, respectively. (B) The B-3-31 repeat was co-transfected with pKV to COLO 320DM cells. The metaphase spread was prepared from the stable transformants selected by blasticidin, and simultaneously hybridized with the DIG-labeled pKV probe and biotin-labeled B-3-31 probe, which was detected using green and red fluorescence, respectively. The D8 repeat (C) or G5 repeat (D) was co-transfected with pΔBM.d2EGFP to COLO 320DM cells. The metaphases spread was hybridized with a probe prepared from the D8 repeat DNA (B) or G5 repeat DNA (C) and visualized as green fluorescence. The DNA was counterstained in blue by 4',6-diamidino-2-phenylindole (B, C) or in red by propidium iodide (D).

Most transformed cells produced by co-transfection of pKV and the B-3-31 repeat harbored the co-amplified plasmid and B-3-31 sequences (Fig 7B). Since the transfection of pKV alone never generated amplified structure, as it is a normal plasmid, this suggest that the B-3-31 repeat can be spontaneously amplified, as in the case of the core IR repeat sequences [30]. We also observed many unusually giant extrachromosomal signals in cells co-transfected with the D8 or G5 repeat (Fig 7C and 7D), which might have been generated from replication anomalies caused by the repeat. These findings suggest that autonomous replication initiation of the repeated sequence might be related to the RIGA phenomenon.

RIGA repeats favored chromosomal amplification

FISH analysis of the metaphase spread from cells using the probe prepared from pΔBM.d2EGFP DNA showed that the IR/MAR-bearing pΔBM.d2EGFP plasmid was amplified in COLO 320DM cells both at the HSR and the DMs (Fig 8), in line with previous results [4]. Surprisingly, there was a strong tendency for co-transfection with the RIGA repeats to cause preferential amplification at the chromosomal HSR (Fig 8).

Fig 8. The RIGS repeat favored extrachromosomal amplification, whereas the RIGA repeat favored chromosomal amplification.

Fig 8

The metaphase spread from the indicated transfection to COLO 320DM cells was subjected to FISH using the probe prepared from pΔBM.d2EGFP DNA. (A) Representative images for the amplification at DMs (arrow heads) or HSR (arrow). (B) Frequency of cells showing amplification of either DMs or HSR, which was counted by examining more than 50 metaphase cells, three times each; data are presented as the mean ± standard deviation.

Discussion

We applied our novel assay system (Fig 1A) based on in vitro ligation followed by intracellular amplification with our original IR/MAR technology to examine the roles of sequence repeats in silencing gene expression. A similar strategy was used in our previous study [30], except here, only used a direct repeat for transfection since the inverted repeat was found to be structurally unstable [30]. With this assay system, the tested sequences could be clearly classified into two main categories: sequences that exhibit RIGS and those that exhibit RIGA. The RIGA phenomenon suggested that the sequence repeat per se does not necessarily silence gene expression but could even upregulate gene expression depending on the specific repeated sequence. This finding helps us to understand the nature and roles of repeat sequences in the mammalian genome, along with direct application value for recombinant production. However, elucidating the underlying mechanism of RIGA or RIGS remains warranted.

One apparent difference between the sequences exhibiting RIGS or RIGA was the CpG and/or AT content. We have previously reported that the 3271-bp B-3-31 sequence did not contain the core region or the non-B structure that typically contribute to gene expression activation [27]. Therefore, we suggested that a low CpG content or high AT content throughout B-3-31 might activate the gene if in proximity to the promoter. However, the present findings demonstrated that bisulfite treatment, which diminished the CpG content and increased the AT content, of the lambda-phage sequence did not influence gene expression, suggesting that even if the CpG/AT content is involved in regulating gene expression, it is not the single determinant. We have found that most repeated sequences generated by the IR/MAR plasmid were CpG hypomethylated, and only few sequences among the repeats were hypermethylated [12]. This was consistent with hypomethylation of CpG at centromeric repeats [40] or transgene arrays [25], both of which were heterochromatinized by RIGS. A recent study showed that integration of CpG-free DNA induced the de novo methylation of CpG islands [41]. Therefore, the hypomethylated state of the repeat might contribute to the hypermethylation of limited sequences by an unknown mechanism, which in turn could initiate heterochromatinization of the entire repeat.

Another apparent feature of the sequences exhibiting RIGA was their influence on replication initiation. We found that the RIGA repeat enhanced the transformation efficiency, generated extraordinarily large extrachromosomal signals, and reduced extrachromosomal gene amplification. This last effect is likely related to our previous finding that double-strand breakage in multiple DMs resulted in their aggregation and elimination from cells, or morphological transformation to the HSR [32, 42]. Thus, a higher level of transcription and/or higher frequency of replication initiation at the RIGA repeat might induce double strand breaks in the amplicon, which could eliminate the DMs or convert them into HSR. Indeed, the core IRs (G5, C12, and D8) should be tightly associated with replication initiation, and the G5 repeat was quite efficiently amplified in cells [30]. Nuclear matrix attachment (i.e., MARs) was suggested to be involved in DNA replication initiation [43, 44]. The B-3-31 repeat initiated gene amplification, whereas the IR (considered the “replicator” of DNA replication or the replication origin) was reported to enhance gene expression [31]. Many reports have demonstrated that the MAR enhanced transgene expression [4547]. Therefore, there is an association between sequences that support replication initiation, sequences that augment gene expression, and the RIGA phenomenon.

Transgene expression in animal cells is typically achieved using a plasmid vector and E. coli host. Herein, we showed that the Amp gene or ColE1 sequence in a plasmid vector exhibited RIGS. This finding is consistent with the ability of a plasmid bacterial sequence to silence cis-ligated transgene expression in animal cells [48], which was subsequently shown to occur in a CpG-independent manner [49]. Therefore, to improve transgene expression, especially using a gene amplification strategy, sequences that exhibit RIGS should be avoided, and those exhibiting RIGA should be preferentially incorporated.

Supporting information

S1 Fig. PCR primers used in this study.

(PPTX)

S2 Fig. Experiment same as Fig 2B, but different transfection.

(PPTX)

S3 Fig. Experiment same as Fig 3A (CHO DG44), but different transfection.

(PPTX)

S1 Raw images

(PDF)

Acknowledgments

We would like to Dr. Ken Tsutsui of Okayama University for kindly gifting the MAR sequences. We would also like to thank the Hiroshima University Natural Science Center for Basic Research and Development for use of the flow cytometer.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

Japan Society for the Promotion of Science, Grant/Award Number: a Grant-in-Aid for Scientific Research (C) (16K081) to N.S. in part. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was supported by AMED under Grant Number JP19ae0101054

References

  • 1.Shimizu N, Miura Y, Sakamoto Y, Tsutsui K. Plasmids with a mammalian replication origin and a matrix attachment region initiate the event similar to gene amplification. Cancer Res. 2001;61(19):6987–6990. [PubMed] [Google Scholar]
  • 2.Shimizu N, Hashizume T, Shingaki K, Kawamoto JK. Amplification of plasmids containing a mammalian replication initiation region is mediated by controllable conflict between replication and transcription. Cancer Res. 2003;63(17):5281–5290. [PubMed] [Google Scholar]
  • 3.Shimizu N, Shingaki K, Kaneko-Sasaguri Y, Hashizume T, Kanda T. When, where and how the bridge breaks: anaphase bridge breakage plays a crucial role in gene amplification and HSR generation. Exp Cell Res. 2005;302(2):233–243. 10.1016/j.yexcr.2004.09.001 [DOI] [PubMed] [Google Scholar]
  • 4.Harada S, Sekiguchi N, Shimizu N. Amplification of a plasmid bearing a mammalian replication initiation region in chromosomal and extrachromosomal contexts. Nuc Acids Res. 2011;39(3):958–969. 10.1093/nar/gkq882 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Tanaka SS, Mitsuda SH, Shimizu N. How a Replication Origin and Matrix Attachment Region Accelerate Gene Amplification under Replication Stress in Mammalian Cells. PLoS ONE. 2014;9(7):e103439 Epub 2014/07/26. 10.1371/journal.pone.0103439 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Shimizu N. Extrachromosomal double minutes and chromosomal homogeneously staining regions as probes for chromosome research. Cytogenet Genome Res. 2009;124(3–4):312–326. 10.1159/000218135 . [DOI] [PubMed] [Google Scholar]
  • 7.Yoshimura H, Sekine S, Adachi H, Uematsu Y, Mitani A, Futaki N, et al. High levels of human recombinant cyclooxygenase-1 expression in mammalian cells using a novel gene amplification method. Protein Exp Purif. 2011;80(1):41–46. Epub 2011/06/08. 10.1016/j.pep.2011.05.009 . [DOI] [PubMed] [Google Scholar]
  • 8.Araki Y, Hamafuji T, Noguchi C, Shimizu N. Efficient Recombinant Production in Mammalian Cells Using a Novel IR/MAR Gene Amplification Method. PLoS ONE. 2012;7(7):e41787 Epub 2012/07/31. 10.1371/journal.pone.0041787 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Noguchi C, Araki Y, Miki D, Shimizu N. Fusion of the Dhfr/Mtx and IR/MAR gene amplification methods produces a rapid and efficient method for stable recombinant protein production. PLoS ONE. 2012;7(12):e52990 Epub 2013/01/10. 10.1371/journal.pone.0052990 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Shimizu N, Hanada N, Utani K, Sekiguchi N. Interconversion of intra- and extra-chromosomal sites of gene amplification by modulation of gene expression and DNA methylation. J Cell Biochem. 2007;102(2):515–529. 10.1002/jcb.21313 . [DOI] [PubMed] [Google Scholar]
  • 11.Utani K, Shimizu N. How transcription proceeds in a large artificial heterochromatin in human cells. Nuc Acids Res. 2009;37(2):393–404. 10.1093/nar/gkn970 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Mitsuda SH, Shimizu N. Epigenetic Repeat-Induced Gene Silencing in the Chromosomal and Extrachromosomal Contexts in Human Cells. PLoS ONE. 2016;11(8):e0161288 Epub 2016/08/16. 10.1371/journal.pone.0161288 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Garrick D, Fiering S, Martin DI, Whitelaw E. Repeat-induced gene silencing in mammals. Nat Genet. 1998;18(1):56–59. 10.1038/ng0198-56 [DOI] [PubMed] [Google Scholar]
  • 14.Hsieh J, Fire A. Recognition and silencing of repeated DNA. Annual Review Genet. 2000;34:187–204. 10.1146/annurev.genet.34.1.187 . [DOI] [PubMed] [Google Scholar]
  • 15.Reddy BD, Wang Y, Niu L, Higuchi EC, Marguerat SB, Bahler J, et al. Elimination of a specific histone H3K14 acetyltransferase complex bypasses the RNAi pathway to regulate pericentric heterochromatin functions. Genes Dev. 2011;25(3):214–219. 10.1101/gad.1993611 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kondo Y, Issa JP. Enrichment for histone H3 lysine 9 methylation at Alu repeats in human cells. J Biol Chem. 2003;278(30):27658–27662. Epub 2003 Apr 30. 10.1074/jbc.M304072200 [DOI] [PubMed] [Google Scholar]
  • 17.McBurney MW, Mai T, Yang X, Jardine K. Evidence for repeat-induced gene silencing in cultured Mammalian cells: inactivation of tandem repeats of transfected genes. Exp Cell Res. 2002;274(1):1–8. 10.1006/excr.2001.5443 [DOI] [PubMed] [Google Scholar]
  • 18.Henikoff S. Conspiracy of silence among repeated transgenes. Bioessays. 1998;20(7):532–535. 10.1002/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.0.CO;2-M [DOI] [PubMed] [Google Scholar]
  • 19.Porokhovnik LN, Lyapunova NA. Dosage effects of human ribosomal genes (rDNA) in health and disease. Chrom Res. 2019;27(1–2):5–17. 10.1007/s10577-018-9587-y . [DOI] [PubMed] [Google Scholar]
  • 20.Martienssen RA. Maintenance of heterochromatin by RNA interference of tandem repeats. Nat Genet. 2003;35(3):213–214. 10.1038/ng1252 [DOI] [PubMed] [Google Scholar]
  • 21.Almeida R, Allshire RC. RNA silencing and genome regulation. Trends Cell Biol. 2005;15(5):251–258. 10.1016/j.tcb.2005.03.006 [DOI] [PubMed] [Google Scholar]
  • 22.He H, Zhang S, Wang D, Hochwagen A, Li F. Condensin Promotes Position Effects within Tandem DNA Repeats via the RITS Complex. Cell Rep. 2016;14(5):1018–1024. 10.1016/j.celrep.2016.01.006 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Peng JC, Karpen GH. H3K9 methylation and RNA interference regulate nucleolar organization and repeated DNA stability. Nature Cell Biol. 2007;9(1):25–35. 10.1038/ncb1514 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Sadaie M, Iida T, Urano T, Nakayama J. A chromodomain protein, Chp1, is required for the establishment of heterochromatin in fission yeast. EMBO J. 2004;23(19):3825–3835. 10.1038/sj.emboj.7600401 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Wang F, Koyama N, Nishida H, Haraguchi T, Reith W, Tsukamoto T. The assembly and maintenance of heterochromatin initiated by transgene repeats are independent of the RNA interference pathway in mammalian cells. Mol Cell Biol. 2006;26(11):4028–4040. Epub 2006/05/18. 10.1128/MCB.02189-05 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Ishak CA, Marshall AE, Passos DT, White CR, Kim SJ, Cecchini MJ, et al. An RB-EZH2 Complex Mediates Silencing of Repetitive DNA Sequences. Mol Cell. 2016;64(6):1074–1087. 10.1016/j.molcel.2016.10.021 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Fukuma M, Ganmyo Y, Miura O, Ohyama T, Shimizu N. Cloning and Characterization of a Human Genomic Sequence that Alleviates Repeat-Induced Gene Silencing. PLoS ONE. 2016;11(4):e0153338 Epub 2016/04/15. 10.1371/journal.pone.0153338 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Hashizume T, Shimizu N. Dissection of mammalian replicators by a novel plasmid stability assay. J Cell Biochem. 2007;101(3):552–565. 10.1002/jcb.21210 . [DOI] [PubMed] [Google Scholar]
  • 29.Okada N, Shimizu N. Dissection of the Beta-Globin Replication-Initiation Region Reveals Specific Requirements for Replicator Elements during Gene Amplification. PLoS ONE. 2013;8(10):e77350 10.1371/journal.pone.0077350 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Ohsaki K, Ohgaki Y, Shimizu N. Amplification of a transgene within a long array of replication origins favors higher gene expression in animal cells. PLoS ONE. 2017;12(4):e0175585 10.1371/journal.pone.0175585 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Fu H, Wang L, Lin CM, Singhania S, Bouhassira EE, Aladjem MI. Preventing gene silencing with human replicators. Nat Biotechnol. 2006;24(5):572–576. Epub 2006 Apr 9. 10.1038/nbt1202 [DOI] [PubMed] [Google Scholar]
  • 32.Shimizu N, Misaka N, Utani K. Nonselective DNA damage induced by a replication inhibitor results in the selective elimination of extrachromosomal double minutes from human cancer cells. Genes Chrom Cancer. 2007;46(10):865–874. 10.1002/gcc.20473 . [DOI] [PubMed] [Google Scholar]
  • 33.Utani K, Kawamoto JK, Shimizu N. Micronuclei bearing acentric extrachromosomal chromatin are transcriptionally competent and may perturb the cancer cell phenotype. Mol Cancer Res. 2007;5(7):695–704. 10.1158/1541-7786.MCR-07-0031 . [DOI] [PubMed] [Google Scholar]
  • 34.Tsutsui K, Okada S, Watarai S, Seki S, Yasuda T, Shohmori T. Identification and characterization of a nuclear scaffold protein that binds the matrix attachment region DNA. J Biol Chem. 1993;268(17):12886–12894. [PubMed] [Google Scholar]
  • 35.Weisenberger DJ, Campan M, Long TI, Kim M, Woods C, Fiala E, et al. Analysis of repetitive element DNA methylation by MethyLight. Nuc Acids Res. 2005;33(21):6823–6836. 10.1093/nar/gki987 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Harada S, Uchida M, Shimizu N. Episomal High Copy Number Maintenance of Hairpin-capped DNA Bearing a Replication Initiation Region in Human Cells. J Biol Chem. 2009;284(36):24320–24327. 10.1074/jbc.M109.008128 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Von Hoff D, Needham-VanDevanter D, Yucel J, Windle B, Wahl G. Amplified human MYC oncogenes localized to replicating submicroscopic circular DNA molecules. Proc Natl Acad Sci USA. 1988;85:4804–4808. 10.1073/pnas.85.13.4804 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Dokmanovic M, Clarke C, Marks PA. Histone deacetylase inhibitors: overview and perspectives. Mol Cancer Res. 2007;5(10):981–989. Epub 2007/10/24. 10.1158/1541-7786.MCR-07-0324 . [DOI] [PubMed] [Google Scholar]
  • 39.Chan CS, Tye BK. Autonomously replicating sequences in Saccharomyces cerevisiae. Proc Natl Acad Sci USA. 1980;77(11):6329–6333. Epub 1980/11/01. 10.1073/pnas.77.11.6329 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Zhang W, Lee HR, Koo DH, Jiang J. Epigenetic modification of centromeric chromatin: hypomethylation of DNA sequences in the CENH3-associated chromatin in Arabidopsis thaliana and maize. Plant Cell. 2008;20(1):25–34. Epub 2008/02/02. 10.1105/tpc.107.057083 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Takahashi Y, Wu J, Suzuki K, Martinez-Redondo P, Li M, Liao HK, et al. Integration of CpG-free DNA induces de novo methylation of CpG islands in pluripotent stem cells. Science. 2017;356(6337):503–508. 10.1126/science.aag3260 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Oobatake Y, Shimizu N. Double-strand breakage in the extrachromosomal double minutes triggers their aggregation in the nucleus, micronucleation, and morphological transformation. Genes Chrom Cancer. 2019;59(3):133–143. 10.1002/gcc.22810 . [DOI] [PubMed] [Google Scholar]
  • 43.Ortega JM, DePamphilis ML. Nucleoskeleton and initiation of DNA replication in metazoan cells. J Cell Sci. 1998;111(Pt 24):3663–3673. [DOI] [PubMed] [Google Scholar]
  • 44.Mesner LD, Hamlin JL, Dijkwel PA. The matrix attachment region in the Chinese hamster dihydrofolate reductase origin of replication may be required for local chromatid separation. Proc Natl Acad Sci USA. 2003;100(6):3281–3286. 10.1073/pnas.0437791100 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Harraghy N, Gaussin A, Mermod N. Sustained transgene expression using MAR elements. Curr Gene Ther. 2008;8(5):353–366. Epub 2008/10/16. 10.2174/156652308786071032 . [DOI] [PubMed] [Google Scholar]
  • 46.Ho SC, Mariati, Yeo JH, Fang SG, Yang Y. Impact of using different promoters and matrix attachment regions on recombinant protein expression level and stability in stably transfected CHO cells. Mol Biotech. 2015;57(2):138–144. Epub 2014/10/14. 10.1007/s12033-014-9809-2 . [DOI] [PubMed] [Google Scholar]
  • 47.Majocchi S, Aritonovska E, Mermod N. Epigenetic regulatory elements associate with specific histone modifications to prevent silencing of telomeric genes. Nuc Acids Res. 2014;42(1):193–204. Epub 2013/09/28. 10.1093/nar/gkt880 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Chen ZY, He CY, Meuse L, Kay MA. Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo. Gene Ther. 2004;11(10):856–864. 10.1038/sj.gt.3302231 . [DOI] [PubMed] [Google Scholar]
  • 49.Chen ZY, Riu E, He CY, Xu H, Kay MA. Silencing of episomal transgene expression in liver by plasmid bacterial backbone DNA is independent of CpG methylation. Mol Ther. 2008;16(3):548–556. 10.1038/sj.mt.6300399 . [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Arthur J Lustig

27 Apr 2020

PONE-D-20-07143

Repeat induces not only gene silencing (RIGS), but also gene activation (RIGA) in mammalian cells

PLOS ONE

Dear Prof. Shimizu,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The following set of changes are required  to address the Reviewers' and AE's comments regarding textual clarity, statistical analysis and scientific rigor:

1. Textual Issues

  • First, the manuscript should be proofread by another investigator familiar with journal publication, to eliminate grammatical errors that are present throughout.  Also please place line numbers in the text for easier textual reviewing.

  • Second, the manuscript is written for a specialty audience.
    • A) The information in the abstract and the manuscript should be accessible to a general audience, eliminating excess technical jargon.
    • B) The introduction should provide more background regarding RIGS, a less technical description of the labs’ previous work, and an elimination of methods/results.  
    • C) The Methods should be describe more fully and include statistical analysis.
    • D) The Results must provide more introductory context (e.g, reason for treatment with butyrate), hypothesis to be tested, and a better textual description of the data presented in the Figures, and a simple conclusion from the data shown.
    • E) In the Discussion, the following statement needs to be explained more fully: “Transgene expression in animal cells is typically achieved using a plasmid vector and E. coli host. Here, we showed that the Amp gene or ColE1 sequence exhibited RIGA. This finding is consistent with the ability of a plasmid bacterial sequence to silence episomal transgene expression [39}.
    • F) The Figure Legends must better describe the data presented, the lane designation, abbreviations, and colors. 

2. Statistical Evaluation: 

  •  Insufficient information is presented including the number of experimental repeats, the statistical tests used, and the statistical significance of any increase or decrease in gene expression (including the modifications suggested Reviewer 2).

3. Scientific Rigor

  • As indicated by Reviewer 1, corrections based on the differing transfection efficiencies must be presented and discussed.

  • Provide the data requested on the number of repeats units introduced after transfection,

  • Provide the clarification of Figures 6 and 7 explained by Reviewer 2. 

  • Provide answers to all additional issues raised by the Reviewers.

  •  Provide all raw data or links to the raw data as given in the Author guidelines.

The first and second reviewers provided non-overlapping but sound critiques.

The AE's evaluation concurred with Reviewers critiques, but also identified required improvements in the text and the determination of statistical significance (as described above) 

We would appreciate receiving your revised manuscript by Jun 11 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Arthur J. Lustig, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels.

In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions.

3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript presents an interesting set of observations and indicates that certain sequences, when repeated, may induce silencing (RIGS) or activate gene expression (RIGA). This type of phenomenon have been known from past studies, however, this work associates gene expression activation with potential replicative properties of the sequences.

Results, although interesting, are not supported by appropriate controls and therefore I found some of the conclusions made by the authors over interpretation of the presented data.

First, experiments are based on transfection and a careful control of transfection efficiency should be presented. In addition, it is not clear how many copies of the initially transfected plasmids are in fact integrated into the genome and how many (if any are in the episomal state). This could be determined by appropriate qPCR approaches.

Finally, all expression determinations are made with a GFP encoding construct under CMV promoter. If this determinations of RIGS and RIGA could address potentially efficiency of recombinant protein production in the cells, a set of different promoters frequently used in mammalian expression systems should be tested to demonstrate universality of the observations.

Minor issues:

The manuscript is well written and presented, however, parts of the introduction are in fact description of the methods/results (page). This should be replace with more general presentation and importance of the subject.

Reviewer #2: In the MS entitled “Repeat induces not only gene silencing (RIGS), but also gene activation (RIGA) in mammalian cells” Ogaki developed an assay system for evaluating the influence of repeat sequences on gene expression, based on in vitro ligation followed by the previously published IR (Initiation Region)/ MAR (Matrix Attachment Region) gene amplification technology in mammalian cell. This technology is use to generate high protein expression in mammalian cells. The novel contribution of the study is the analysis of human genomic repeats (e.g. LINEs, Alus), some other no specified repeats found in the genome named (B-3-31) that enhanced gene expression from tandemly amplified repeats and some core sequences from different initiation regions that the authors called C12, D8, and G5. The Shimizu lab has a great deal of experience using the IR/MAR technology applied in this study. The author’s results, therefore, highlights the potential of repeat sequences may downregulate (RIGS) or upregulate (RIGA) the expression of eGFP using the IR/MAR system. The manuscript is well written and it fits well with the scope of the journal. After the revisions have been done, I recommend publishing this article.

I have read this paper several times and submit these recommendations to you:

Results:

It will be helpful if Figure 1D it is described in more detail in the figure legend. Please add sizes of the band for each gel and define the abbreviation M and L in the figure legend.

For Figure 2, add a graph that summarizes the % eGFP cells and the fold effects of significant differences using the mean. The way the data is shown and the description in the results and figure legend implies that the experiments were done only one time (n=1). Do this for A, B, C, D. Please add statistical analysis to the graphs.

Figure 3 and 4 do the same as described for Figure 2.

For Figure 5C and 5D do the same as described for Figure 2.

For Figure 6A the figure legend describes “the colony number per dish was counted and plotted; a small and large colony was defined as a colony comprising less than or more than 100 cells, respectively”. The manuscript does not explain why the size is important. Please explain why the data was presented this way. Is there an actual physical measure you used to determine 100 cells? If so, please add to the figure legend.

Figure 7B 3rd graph showing RIGS looks the same as baseline pBM-d2EGFP. Please shoe the % of the DMs. This data does not support that RIGS result in “preferential amplification at the extrachromosomal DMs” as stated in the results. Especially when you compared the baseline pBM-d2EGFP from the RIGA experiments.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 1

Arthur J Lustig

10 Jun 2020

Repeat induces not only gene silencing, but also gene activation in mammalian cells

PONE-D-20-07143R1

Dear Dr. Shimizu,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Arthur J. Lustig, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The Authors made significant improvements in the manuscript. All reviewer comments and criticisms were addressed by appropriate changes in the text of explanation/refences to their previous work.

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Acceptance letter

Arthur J Lustig

15 Jun 2020

PONE-D-20-07143R1

Repeat induces not only gene silencing, but also gene activation in mammalian cells

Dear Dr. Shimizu:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Arthur J. Lustig

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. PCR primers used in this study.

    (PPTX)

    S2 Fig. Experiment same as Fig 2B, but different transfection.

    (PPTX)

    S3 Fig. Experiment same as Fig 3A (CHO DG44), but different transfection.

    (PPTX)

    S1 Raw images

    (PDF)

    Attachment

    Submitted filename: Response_to_Reviewers_.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES